Rigid Endoscopes Market Share

North American Market Forecast

North America industry is predicted to dominate majority revenue share of 38% by 2037, as a result of the increasing awareness about endoscopic surgeries for the diagnosis and treatment of various acute and chronic diseases. In the coming years, the region is also expected to present lucrative growth opportunities for market expansion due to rising cancer tumor prevalence, strong healthcare infrastructure, and the availability of prominent key players. According to the American Cancer Society, more than 1.8 million new cases of cancer were identified in the U.S. in 2021.

APAC Market Analysis

The rigid endoscopes market in Asia Pacific will register a revenue share of more than 28% by the end of 2037. The market is expanding as a result of the region's growing preference for elective endoscopic surgeries, increased healthcare spending, and a rapidly growing geriatric population. According to the World Health Organization, the proportion of people aged 60 years and above in the South East Asia region was 9.5% in 2017, and it is expected to rise to 13.2% and 19.8% by 2030 and 2050, respectively.